Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Bioxyne Limited

Investor presentation - Bioxyne Limited

ASX:BXN

Bioxyne Limited

Health

Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012

Read more

Market Cap

$8.96m

Price at Close

$0.014

4w avg. Volume

280.86k

4w avg. Turnover

$3.73k

Announcements
announcementt+2 movementdate
  • Results of Meeting

    Notice Of Meeting

  • 0.00%

    26 Nov 2020

0.00%

26 Nov 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • 0.00%

    27 Oct 2020

0.00%

27 Oct 2020
  • Appendix 4G and Corporate Governance

    Periodic Reports

  • 0.00%

    30 Sep 2020

0.00%

30 Sep 2020
  • Annual Report to shareholders

    Periodic Reports

  • 0.00%

    30 Sep 2020

0.00%

30 Sep 2020
  • Preliminary Final Report

    Periodic Reports · Market sensitive

  • 0.00%

    30 Aug 2020

0.00%

30 Aug 2020
  • Response to ASX Price Query

    ASX Query · Market sensitive

  • -22.22%

    20 Aug 2020

-22.22%

20 Aug 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • -21.43%

    30 Jul 2020

-21.43%

30 Jul 2020
  • Appendix 4C Revised

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    01 May 2020

0.00%

01 May 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    30 Apr 2020

0.00%

30 Apr 2020
Market Data

Current Price

$0.014

52WK HIGH

$0.024

52WK LOW

$0.007

1YR RETURN

-17.65%

1YR RETURN VS. SECTOR

-57.91%

90 DAY RETURN

-6.67%

ASX RANK

1,845

/2,048

SECTOR RANK

163

/168

SHARES OUTSTANDING

640.15m
ASX:BXN

Bioxyne Limited

Health

Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012

Read more

Market Cap

$8.96m

Price at Close

$0.014

4w avg. Volume

280.86k

4w avg. Turnover

$3.73k

ASX:BXN is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.